Apel Daniel Joseph 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Jan 8, 2026
Insider Transaction Report
Form 4
Apel Daniel Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2026-01-06+75,000→ 176,200 total
Footnotes (2)
- [F1]Represents shares underlying restricted stock units which will vest in four equal annual installments.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.